Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New Drugs 2021, Part 2.

Daniel A Hussar1

  • 1DEAN EMERITUS AND REMINGTON PROFESSOR EMERITUS • PHILADELPHIA COLLEGE OF PHARMACY UNIVERSITY OF THE SCIENCES • PHILADELPHIA, PA.

Nursing
|September 28, 2021
PubMed
Summary
This summary is machine-generated.

This article reviews eight new medications, including the first treatment for SARS-CoV-2, a novel HIV drug, and an IV painkiller for adults. These advancements offer new therapeutic options for critical health conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New Drugs 2021, Part 1.

Nursing·2021
Same author

New Drug Update 2020.

The Senior care pharmacist·2021
Same author

New drugs 2020, part 3.

Nursing·2020
Same author

Is the Quality of Generic Drugs Cause for Concern?

Journal of managed care & specialty pharmacy·2020
Same author

New Drugs 2020, part 2.

Nursing·2020
Same author

2020 New Drug Update.

The Senior care pharmacist·2020
Same journal

Bridging disciplines through Alzheimer care: A faculty-guided summer interprofessional education experience for prelicensure nursing students.

Nursing·2026
Same journal

Improving outcomes by empowering nurses to lead change in an acute stroke unit.

Nursing·2026
Same journal

Q&A with Ken Wofford, PhD, CRNA, CHSE, FAWM, DiMM.

Nursing·2026
Same journal

Oral anticoagulant medications.

Nursing·2026
Same journal

Signs, signs, everywhere a sign!

Nursing·2026
Same journal

How does postural orthostatic tachycardia syndrome (POTS) affect pediatric patients?

Nursing·2026
See all related articles

Area of Science:

  • Pharmacology and Therapeutics
  • Infectious Diseases
  • Pain Management

Background:

  • This article is the second in a series detailing recent pharmaceutical approvals.
  • It focuses on eight newly authorized medications across various medical fields.

Discussion:

  • Highlights include the first FDA-approved drug for treating SARS-CoV-2 (COVID-19).
  • A first-in-class HIV attachment inhibitor represents a significant advancement in antiretroviral therapy.
  • A new intravenous injection offers an alternative for managing severe acute pain in adults unresponsive to other treatments.

Key Insights:

  • The review covers critical therapeutic areas: viral infections, chronic diseases, and pain management.
  • Novel drug mechanisms, such as HIV attachment inhibition, are discussed.

Related Experiment Videos

  • The introduction of new treatment modalities addresses unmet medical needs.

    • Outlook:

    • These recent drug approvals signify progress in pharmaceutical innovation.
    • Future research may build upon these advancements to develop more effective therapies.
    • The availability of these new drugs is expected to improve patient outcomes.